ISSN : 2663-2187

From Crisis to Control: A Comprehensive Review of Biomedical Waste Management in the COVID-19 Era

Main Article Content

Dr Harishma Ramesh Dr Vinoth Gnana Chellaiyan Devanbu Dr Vedapriya Dande Rajasekar Vijayalakshmi Sridharan Dr Sanjutha A Arun Kumar R Rajan Edward Daniel Thomas Dr. Harishma Ramesh
ยป doi: 10.33472/AFJBS.6.9.2024.979-989

Abstract

The World Health Organization (WHO) has reported 767,972,961 confirmed COVID-19 cases globally, including 6,950,655 deaths, as of July 2023. The emergence of this novel disease, which began in December 2019 and was later declared a pandemic by the WHO on March 11, 2020, has played a significant role in the increase of biomedical waste (BMW). The rapid rise in the number of cases and the highly contagious nature of the disease have put tremendous strain on hospital waste management systems worldwide. During the pandemic, different countries adopted various additional measures to reduce biomedical waste (BMW) generation to avoid any future waste pandemic. In general, all facilities globally addressed the following strategies: Compliance with provided guidelines, Assignment of a person in charge of the biomedical waste at all levels and description of their responsibilities, Provision of clear definitions and classifications of healthcare waste, Implementation of specific procedures for handling the waste generated, and Provision of training for all related workers. Although the classification and treatment of waste differ between countries, most agree that waste management starts with segregation at the point of generation. Training waste handlers in healthcare facilities can bring about a significant change in waste management. The strength of biomedical waste management lies in the strong coordination between different government bodies, ensuring that BMW is safely treated and disposed of. More research and development of newer technology will provide opportunities for reducing the burden of BMW in the future

Article Details